164 related articles for article (PubMed ID: 21181210)
21. A qualitative exploration of patient and healthcare professionals' views and experiences of palliative rehabilitation during advanced lung cancer treatment.
Payne C; McIlfatrick S; Larkin P; Dunwoody L; Gracey J
Palliat Med; 2018 Dec; 32(10):1624-1632. PubMed ID: 30180786
[TBL] [Abstract][Full Text] [Related]
22. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.
Poolman M; Roberts J; Wright S; Hendry A; Goulden N; Holmes EA; Byrne A; Perkins P; Hoare Z; Nelson A; Hiscock J; Hughes D; O'Connor J; Foster B; Reymond L; Healy S; Lewis P; Wee B; Johnstone R; Roberts R; Parkinson A; Roberts S; Wilkinson C
Health Technol Assess; 2020 May; 24(25):1-150. PubMed ID: 32484432
[TBL] [Abstract][Full Text] [Related]
23. Breakthrough cancer pain: an observational study of 1000 European oncology patients.
Davies A; Buchanan A; Zeppetella G; Porta-Sales J; Likar R; Weismayr W; Slama O; Korhonen T; Filbet M; Poulain P; Mystakidou K; Ardavanis A; O'Brien T; Wilkinson P; Caraceni A; Zucco F; Zuurmond W; Andersen S; Damkier A; Vejlgaard T; Nauck F; Radbruch L; Sjolund KF; Stenberg M
J Pain Symptom Manage; 2013 Nov; 46(5):619-28. PubMed ID: 23523361
[TBL] [Abstract][Full Text] [Related]
24. 'I am part of the community but...' The changing context of rural living for persons with advanced cancer and their families.
Duggleby WD; Penz K; Leipert BD; Wilson DM; Goodridge D; Williams A
Rural Remote Health; 2011; 11(3):1733. PubMed ID: 21787109
[TBL] [Abstract][Full Text] [Related]
25. Circadian variation of breakthrough pain in cancer patients.
Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A
Eur J Pain; 2013 Feb; 17(2):264-70. PubMed ID: 22715071
[TBL] [Abstract][Full Text] [Related]
26. European Oncology Nursing Society breakthrough cancer pain guidelines.
Wengström Y; Geerling J; Rustøen T
Eur J Oncol Nurs; 2014 Apr; 18(2):127-31. PubMed ID: 24369817
[TBL] [Abstract][Full Text] [Related]
27. Pan-European, open-label dose titration study of fentanyl buccal tablet in patients with breakthrough cancer pain.
Kleeberg UR; Davies A; Jarosz J; Mercadante S; Poulain P; O'Brien T; Schneid H; Kress HG
Eur J Pain; 2015 Apr; 19(4):528-37. PubMed ID: 25181451
[TBL] [Abstract][Full Text] [Related]
28. Breakthrough cancer pain (BTcP) management: a review of international and national guidelines.
Davies AN; Elsner F; Filbet MJ; Porta-Sales J; Ripamonti C; Santini D; Webber K
BMJ Support Palliat Care; 2018 Sep; 8(3):241-249. PubMed ID: 29875184
[TBL] [Abstract][Full Text] [Related]
29. The management of breakthrough cancer pain--educational needs a European nursing survey.
Wengström Y; Rundström C; Geerling J; Pappa T; Weisse I; Williams SC; Zavratnik B; Rustøen T
Eur J Cancer Care (Engl); 2014 Jan; 23(1):121-8. PubMed ID: 24079835
[TBL] [Abstract][Full Text] [Related]
30. Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settings.
Mercadante S; Lazzari M; Reale C; Cuomo A; Fusco F; Marchetti P; Mediati RD; Chiurazzi B; Ciuffedra L; Caraceni A; Iaffaioli V; Luzzani M; Micheletto G; Papa A; Raffaeli W; Valle A; Caruso M; Di Costanzo F; Pinato G; Nardi F; Barni S; Natoli S; Mammucari M; Sabato AF; Dauri M;
Clin J Pain; 2015 Mar; 31(3):214-21. PubMed ID: 25654429
[TBL] [Abstract][Full Text] [Related]
31. Intranasal fentanyl versus fentanyl pectin nasal spray for the management of breakthrough cancer pain in doses proportional to basal opioid regimen.
Mercadante S; Prestia G; Adile C; Casuccio A
J Pain; 2014 Jun; 15(6):602-7. PubMed ID: 24561001
[TBL] [Abstract][Full Text] [Related]
32. Barriers to the use of buccal and intranasal fentanyl for breakthrough pain in paediatric palliative care: an exploratory survey.
Harrop E; Jamieson L; Choy TH; Ho WHP; Wong ICK
BMJ Support Palliat Care; 2018 Sep; 8(3):355-356. PubMed ID: 28801316
[No Abstract] [Full Text] [Related]
33. How do nurses in specialist palliative care assess and manage breakthrough cancer pain? A multicentre study.
Soden K; Ali S; Alloway L; Barclay D; Barker S; Bird L; Hall L; Perkins P
Int J Palliat Nurs; 2013 Nov; 19(11):528-34. PubMed ID: 24263896
[TBL] [Abstract][Full Text] [Related]
34. Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study.
Katz NP; Gajria KL; Shillington AC; Stephenson JJ; Harshaw Q
Postgrad Med; 2017 Jan; 129(1):32-39. PubMed ID: 27846789
[TBL] [Abstract][Full Text] [Related]
35. [Experiences of cancer patients with breakthrough pain and pharmacological treatments].
Bertram L; Stiel S; Elsner F; Radbruch L; Davies A; Nauck F; Alt-Epping B
Schmerz; 2010 Dec; 24(6):605-12. PubMed ID: 21046170
[TBL] [Abstract][Full Text] [Related]
36. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.
Mercadante S; Ferrera P; Adile C; Casuccio A
J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977
[TBL] [Abstract][Full Text] [Related]
37. Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI--Italian questionnaire for intense episodic pain.
Caraceni A; Bertetto O; Labianca R; Maltoni M; Mercadante S; Varrassi G; Zaninetta G; Zucco F; Bagnasco M; Lanata L; De Conno F;
J Pain Symptom Manage; 2012 May; 43(5):833-41. PubMed ID: 22560355
[TBL] [Abstract][Full Text] [Related]
38. Patient Satisfaction with Fentanyl Sublingual Spray in Opioid-Tolerant Patients with Breakthrough Cancer Pain.
Rauck R; Parikh N; Dillaha L; Barker J; Stearns L
Pain Pract; 2015 Jul; 15(6):554-63. PubMed ID: 25060406
[TBL] [Abstract][Full Text] [Related]
39. Usability testing of an electronic pain monitoring system for palliative cancer patients: A think-aloud study.
Taylor S; Allsop MJ; Bennett MI; Bewick BM
Health Informatics J; 2019 Sep; 25(3):1133-1147. PubMed ID: 29172951
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain.
Shimoyama N; Gomyo I; Teramoto O; Kojima K; Higuchi H; Yukitoshi N; Ohta E; Shimoyama M
Jpn J Clin Oncol; 2015 Feb; 45(2):189-96. PubMed ID: 25378647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
